Exploring how cancer changes cell chemistry to improve treatment options
Unlocking the Chemical Space of Cancer-Associated Perturbations
This study is looking at the chemical changes in cancer cells to help create better treatments that are tailored to the specific features of each patient's tumor, aiming to improve how we understand and fight cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10899748 on NIH RePORTER |
What this research studies
This research investigates the chemical changes that occur in cancer cells, focusing on how these changes can inform more effective treatments. By analyzing the unique proteins and biochemical processes involved in tumor development, the study aims to create new methods for understanding cancer biology. Patients may benefit from this research as it seeks to develop targeted therapies based on the specific characteristics of their tumors, moving beyond traditional genetic profiling. The approach combines advanced techniques in chemistry and biology to provide a deeper understanding of cancer mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients who are undergoing treatment and have specific tumor types that may benefit from targeted therapies.
Not a fit: Patients with non-cancerous conditions or those whose tumors do not exhibit unique biochemical changes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments tailored to individual patients' tumor characteristics.
How similar studies have performed: Other research has shown promise in using biochemical profiling to inform cancer treatment, indicating that this approach could lead to significant advancements in precision oncology.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Brady, Donita C — University of Pennsylvania
- Study coordinator: Brady, Donita C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.